Fred Aslan

President and CEO

Fred Aslan (President and CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Artiva Biotherapeutics, Inc. (ARTV). The largest single filing was $690K of ARTV (61,888 sh × $11.16, as filed), executed Sep 3.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.3M

shares × price, as filed

Last traded

Sep 8

Filed Sep 9

Median ADV $6.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

ARTV

Artiva Biotherapeutics, Inc. ARTV · 0 buys · 4 sells 4 filings

Recent filings

ARTVSALE Artiva Biotherapeutics, Inc. View filing → $256K
23,429 sh × $10.92
Exec Sep 8
Filed Sep 9 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $690K
61,888 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $244K
27,116 sh × $9.01
Exec May 19
Filed May 19 · 5:30 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $153K
25,500 sh × $6.00
Exec Oct 17 2025
Filed Oct 17 2025 · 5:30 PM ET